08.03.2014 Views

Israel Medica2010 Companies Catalogue - Israeli-South African ...

Israel Medica2010 Companies Catalogue - Israeli-South African ...

Israel Medica2010 Companies Catalogue - Israeli-South African ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

The <strong>Israel</strong> Export &<br />

International Cooperation Institute<br />

<strong>Israel</strong> at<br />

MEDICA 2010<br />

Hall 16 - G28, G37, G40 | Hall 5 - M19 | Hall 3 - E44<br />

November 17-20 | Düsseldorf, Germany


<strong>Israel</strong>: Life Science Powerhouse<br />

<strong>Israel</strong>i physicians, scientists, researchers and engineers have propelled the country's Medical Device industry to the<br />

leading edge of innovation and creativity, spanning all fields of medicine.<br />

Quick facts:<br />

• <strong>Israel</strong> is considered to be the second largest supplier of Medical Device solutions worldwide.<br />

• <strong>Israel</strong> ranks #1 in Medical Device patents per capita (#4 in absolute figures).<br />

• There are over 1,100 life science companies in <strong>Israel</strong>; 65% of them are Medical Device firms.<br />

Several global medical corporations have found <strong>Israel</strong>i companies to be attractive business partners. <strong>Israel</strong>i<br />

companies have proven their excellence in R&D, and in implementing breakthrough technologies in the Medical<br />

Device industry. Some of the leading multinationals holding equity positions in <strong>Israel</strong> include GE Medical, Philips,<br />

Siemens, Boston Scientific, Johnson & Johnson, and Medtronic.<br />

A strong entrepreneurial spirit pervades <strong>Israel</strong>i society. Perhaps fueled by a young country’s need to develop<br />

creative solutions quickly and cost-effectively, or inspired by improvisation and calculated risk-taking, it seems that<br />

innovation is an <strong>Israel</strong>i way of life.<br />

• <strong>Israel</strong>’s 16 Technology Transfer Organizations (TTOs) showcase the creative fusion between universities,<br />

hospital systems, businesses and the military. All of the TTOs are dedicated to encouraging and promoting<br />

research projects and military technology from the lab to the world market.<br />

• Healthcare is a priority in a well-educated country. <strong>Israel</strong> spends 8% of its GDP on healthcare. It boasts a very<br />

high level of healthcare and an extensive infrastructure of quality resources that range from local community<br />

clinics to world-renowned trauma centers. The country has a high ratio of MDs to population (3.5 per 1,000).<br />

The country’s entrepreneurial spirit runs through this sector as well: Many <strong>Israel</strong>i physicians are both early<br />

adopters of new technologies and developers of original technologies in their own right.<br />

• <strong>Israel</strong> has a highly skilled workforce. The country has the greatest number of scientists and engineers per<br />

capita in the world; 24% of the workforce have academic degrees.<br />

• The defense community nurtures the life science industry. Extensive investment in developing state-of-the-art<br />

technologies for defense has proved fertile ground for advanced life science applications. Two very wellknown<br />

innovations emerged from Rafael Advanced Defense Systems: PillCam TM , a video capsule endoscope<br />

(developed by Given Imaging), and cryotherapy for the treatment of cancer (developed by Galil Medical).<br />

• Strong institutional incentives support the development of new technologies. The 23 government-licensed<br />

technological incubators, which began in the 1990s as a way to provide employment opportunities for new<br />

immigrant scientists and engineers (many from the former Soviet Union), has evolved as a successful<br />

framework for advancing and commercializing early-stage life science technologies. In fact, in 2008,<br />

approximately 38% of the 1,175 incubator graduate companies continued beyond the incubator stage to<br />

function as mature companies.<br />

Nearly half of <strong>Israel</strong>’s technological incubators focus on the life sciences or biotechnology. At the end of 2008,<br />

41% of all incubated companies were involved in medical devices, and 18% in biotechnology. Of the $360<br />

million in grant money awarded to incubator companies by <strong>Israel</strong>’s Office of the Chief Scientist in 2008, 25.4%<br />

went to those involved in the life sciences.<br />

• The world’s venture capital community keeps its focus on <strong>Israel</strong>. In 2008, about 80 <strong>Israel</strong>i and international VC<br />

companies targeted specific investment efforts on <strong>Israel</strong>. Of these, nine are focused solely on life sciences.<br />

For more information:<br />

Ms. Angelica Khachaturov, Business Development Manger – Medical Device & Healthcare IT, <strong>Israel</strong> Export &<br />

International Cooperation Institute | Tel: +972-3-514-2986 | Fax: +972-3-514-2881 | angelica@export.gov.il<br />

2


The <strong>Israel</strong> Export & International Cooperation Institute (IEICI)<br />

The <strong>Israel</strong> Export & International Cooperation Institute, supported by member firms, private sector bodies<br />

and the government of <strong>Israel</strong>, advances business relationships between <strong>Israel</strong>i exporters and overseas<br />

businesses and organizations. By providing a wide range of export-oriented services to <strong>Israel</strong>i<br />

companies and complementary services to the international business community, the Institute helps build<br />

successful joint ventures, strategic alliances and trade partnerships.<br />

The IEICI’s Life Science Department is the leader in business matching between the more than 1,200<br />

companies in the <strong>Israel</strong>i life science industry and worldwide business partners at all levels. It has a<br />

proven ability to identify and match suitable potential business partners, organize one-on-one<br />

business meetings, and is a focal point for contacts with the government as well as with industry.<br />

The IEICI is the major organizer of <strong>Israel</strong>i company participation at Medica 2010.<br />

Visit the IEICI at Medica, Hall 16 Booth G40. www.export.gov.il/ls<br />

Foreign Trade Administration<br />

Ministry of Industry, Trade and Labor<br />

The Foreign Trade Administration of the Ministry of Industry, Trade and Labor manages and directs the<br />

State of <strong>Israel</strong>’s international trade policy. The Administration's main fields of activity include activities for<br />

the promotion of international trade and exports, negotiating and maintaining trade agreements for<br />

improving <strong>Israel</strong>’s trade network, attracting and encouraging foreign investments, and creating strategic<br />

alliances with foreign companies. In addition to its activities in <strong>Israel</strong>, the Administration operates a<br />

network of economic representatives, who act as the ministry’s operational arm in markets abroad.<br />

Objectives:<br />

• Assisting <strong>Israel</strong>i industry in deepening its activities in existing markets and penetrating new markets.<br />

• Accompanying and supporting individual exporters in their marketing activity abroad.<br />

• Negotiating and implementing international trade agreements, and maintaining existing agreements.<br />

• Promoting investments and strategic partnerships.<br />

• Promoting the image of the <strong>Israel</strong>i industry and economy abroad.<br />

For more information, visit www.trade.gov.il<br />

3


Table of Contents<br />

Medical Device <strong>Companies</strong> Index<br />

Aesthetics and Dermatology<br />

• Cnoga………………………………………………………………………………………………………... 16<br />

• CoolSense Medical………………………………………………………………………………………… 18<br />

• Erika Carmel………………………………………………………………………………………………… 23<br />

• TavTech……………………………………………………………………………………………………… 49<br />

Cardiovascular and Peripheral Vascular<br />

• BSP Biological Signal Processing………………………………………………………………………... 14<br />

• C-Boot……………………………………………………………………………………………………….. 15<br />

• Flexicath……………………………………………………………………………………………………... 26<br />

• HypnoCore…………………………………………………………………………………………………... 30<br />

• Itamar Medical……………………………………………………………………………………………… 32<br />

• VitalCare Medical…………………………………………………………………………………………... 50<br />

Diagnostics<br />

• 3QBD………………………………………………………………………………………………………… 8<br />

• BSP Biological Signal Processing………………………………………………………………………... 14<br />

• Cnoga………………………………………………………………………………………………………... 16<br />

• Common Sense……………………………………………………………………………………………... 17<br />

• Elitr Advanced Systems……………………………………………………………………………………. 20<br />

• Elsmed Medical Systems…………………………………………………………………………………... 22<br />

• Hypnocore…………………………………………………………………………………………………... 30<br />

• Itamar Medical……………………………………………………………………………………………… 32<br />

• Medoc………………………………………………………………………………………………………... 35<br />

• Sialo Technologies………………………………………………………………………………………… 44<br />

• SPO Medical Technologies………………………………………………………………………………... 47<br />

• VitalCare Medical…………………………………………………………………………………………... 50<br />

Disposable and Implantable<br />

• Albaad……………………………………………………………………………………………………….. 10<br />

• ETView……………………………………………………………………………………………………….. 24<br />

• First Care Products………………………………………………………………………………………… 25<br />

• Flexicath……………………………………………………………………………………………………... 26<br />

• Hanita Lenses……………………………………………………………………………………………….. 29<br />

• Intromedix…………………………………………………………………………………………………... 31<br />

• Mizra Medical……………………………………………………………………………………………….. 36<br />

• Sion Biotext Medical……………………………………………………………………………………….. 46<br />

Endoscopes and Accessories<br />

• Orpheus……………………………………………………………………………………………………... 39<br />

• Sialo Technologies………………………………………………………………………………………… 44


E.M.S.<br />

• Beth-El Zikhron Yaaqov Industries……………………………………………………………………… 12<br />

• ETView……………………………………………………………………………………………………….. 24<br />

• First Care Products………………………………………………………………………………………… 25<br />

• Flight Medical……………………………………………………………………………………………….. 27<br />

Gynecology and Women’s Health<br />

• 3QBD………………………………………………………………………………………………………… 8<br />

• ACU Medical Technologies………………………………………………………………………………... 9<br />

• Artisan Sonics………………………………………………………………………………………………. 11<br />

• Common Sense……………………………………………………………………………………………... 17<br />

• Elmedical…………………………………………………………………………………………………….. 21<br />

Hospital Equipment<br />

• Beth-El Zikhron Yaaqov Industries ……………………………………………………………………… 12<br />

• Coolsense Medical………………………………………………………………………………………… 18<br />

• EarlySense…………………………………………………………………………………………………... 19<br />

• Elsmed Medical Systems…………………………………………………………………………………... 22<br />

• ETView……………………………………………………………………………………………………….. 24<br />

• Flight Medical……………………………………………………………………………………………….. 27<br />

• Haldor Advanced Technologies………………………………………………………………………….. 28<br />

• Intromedix…………………………………………………………………………………………………... 31<br />

• NanoVibronix……………………………………………………………………………………………….. 37<br />

• OHK Medical Devices………………………………………………………………………………………. 38<br />

• Pegasus Medical Concepts……………………………………………………………………………….. 40<br />

• Polytex Technologies……………………………………………………………………………………… 41<br />

• Q-Core Medical…………………………………………………………………………………………….. 42<br />

• Shekel Scales………………………………………………………………………………………………... 43<br />

• SPO Medical Systems……………………………………………………………………………………… 47<br />

Infection Control and Infectious Diseases<br />

• Albaad………………………………………………………………………………………………………... 10<br />

• Beth-El Zikhron Yaaqov Industries………………………………………………………………………. 12<br />

• Mizra Medical……………………………………………………………………………………………….. 36<br />

• NanoVibronix………………………………………………………………………………………………. 37<br />

• Sion Biotext Medical……………………………………………………………………………………….. 46<br />

Industrial OEM<br />

• Albaad………………………………………………………………………………………………………... 10<br />

• B.R.F. Engineering…………………………………………………………………………………………... 13<br />

• Shekel Scales………………………………………………………………………………………………... 43<br />

Ophthalmology<br />

• Hanita Lenses ………………………………………………………………………………………………. 23<br />

• Sion Biotext Medical……………………………………………………………………………………….. 26<br />

• Talshir Medical Technologies…………………………………………………………………………….. 48<br />

5


Orthopedic<br />

• Erika Carmel ………………………………………………………………………………………………… 23<br />

• Flexicath…………………………………………………………………………………………………….. 26<br />

• Meditouch…………………………………………………………………………………………………… 34<br />

• OHK Medical Devices……………………………………………………………………………………..... 38<br />

• Sion Biotext Medical………………………………………………………………………………………. 46<br />

Respiratory and Pulmonary<br />

• ETView……………………………………………………………………………………………………….. 24<br />

• Flight Medical………………………………………………………………………………………………. 27<br />

• Hypnocore…………………………………………………………………………………………………... 30<br />

• Itamar Medical……………………………………………………………………………………………… 32<br />

Services<br />

• 2P2D Solutions…………………………………………………………………………………………….. 7<br />

• B.R.F. Engineering…………………………………………………………………………………………... 13<br />

• Medical Market Bridge……………………………………………………………………………………. 33<br />

• Signal Business Development……………………………………………………………………………. 45<br />

Telemedicine and Healthcare IT<br />

• 2P2D Solutions……………………………………………………………………………………………... 7<br />

• Artisan Sonix………………………………………………………………………………………………... 11<br />

• Elitr Advanced Systems……………………………………………………………………………………. 20<br />

• Hypnocore…………………………………………………………………………………………………... 30<br />

• Meditouch………………………………………………………………………………………………….... 34<br />

• Orpheus……………………………………………………………………………………………………… 39<br />

• Shekel Scales………………………………………………………………………………………………... 43<br />

Urology<br />

• Elmedical…………………………………………………………………………………………………….. 21<br />

• Mizra Medical……………………………………………………………………………………………….. 36<br />

• NanoVibronix……………………………………………………………………………………………….. 37<br />

Wound Management and Pain Management<br />

• C-Boot……………………………………………………………………………………………………….. 15<br />

• Erika Carmel………………………………………………………………………………………………… 23<br />

• Medoc………………………………………………………………………………………………………... 35<br />

• NanoVibronix……………………………………………………………………………………………….. 37<br />

• Sion Biotext Medical……………………………………………………………………………………….. 46<br />

6


2P2D Solutions Ltd.<br />

Back to TOC<br />

www.2p2d.com<br />

Company at a Glance<br />

2P2D Solutions Ltd. is a pioneering technology-based company developing unique solutions for various<br />

unmet needs within the healthcare, biotech and pharmaceutical industries.<br />

2P2D Solutions Ltd. has developed a breakthrough automated drug monitoring system for use in<br />

clinical drug trials that incorporates a portable, personalized medication dispensing device using<br />

proprietary 2P2D technology.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Medical Devices, Healthcare IT<br />

Telemedicine, Medication Management, Services, CRO<br />

Therapeutic Area(s):<br />

Company Status:<br />

R&D, Proof of Concept<br />

Technology & Product(s)<br />

• 2P2D Solutions Ltd. has developed ClinicAid, a breakthrough automated drug monitoring system that<br />

incorporates a portable medication dispensing device using proprietary 2P2D technology. The system<br />

dispenses personalized drug dosages designated for each specific patient or group of patients. For<br />

safety reasons, the drug is dispensed only after patient identification has been fully authenticated, and<br />

according to the designated clinical trial treatment regimen. This exclusive medication management<br />

system, for use in clinical drug trials, ensures unequaled compliance, accountability and accuracy.<br />

• The Company’s telemedicine solution provides:<br />

• Complete and real-time knowledge of the participant’s compliance and adherence to the trial protocols.<br />

• Reduced overall duration of the clinical trial period.<br />

• Increased participant compliance and adherence to the given medication.<br />

• Cost effective solution for clinical trial packaging and drug accountability.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Investment, Strategic Alliances<br />

CROs, pharma companies,hospitals<br />

Worldwide<br />

7


3QBD<br />

Back to TOC<br />

www.3qbd.com<br />

Company at a Glance<br />

Located in Arad, <strong>Israel</strong>, 3QBD Ltd. is an ISO certified startup medical device company. The company has<br />

developed the VGTest, a gynecological diagnostic device based on Ion Mobility Spectrometry (IMS) which is<br />

used in the detection of vaginal infections.<br />

In December 2009, 3QBD Ltd. received the European CE mark for the VGTest, a device capable of detecting<br />

and returning a positive/negative result for Bacterial Vaginosis, the most prevalent women’s vaginal<br />

infection, within 60 seconds.<br />

Future development plans for 3QBD include expanding research further into the medical field, to detect<br />

additional major infections and diseases and offer rapid, accurate results. Other applications for the<br />

technology include cancer, food and livestock.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Diagnostics<br />

Gynecology, Obstetrics, Women's Health<br />

Clinical Trials, Regulatory Approval<br />

Technology & Product(s)<br />

IMS (Ion Mobility Spectrometry) Technology<br />

3QBD's technology is based on the well-established and scientifically proven Ion Mobility Spectrometry<br />

(IMS) technology – first used successfully to detect drugs and explosives. Today IMS is being used to detect<br />

presence and type of infection.<br />

Chemical changes in living systems, or degradation of cells after death through enzymatic and microbial<br />

processes, are accompanied by the breakdown of amino acids and production of biogenic amines.<br />

Pathological conditions in the human body may be expressed in the formation of biogenic amines, so that<br />

elevated levels of biogenic amines may be indicative of dysfunctions. IMS is a sensitive instrumental<br />

technique for detecting volatile compounds. It is based on measuring the velocity of ions (ion mobility)<br />

drifting through a gas bath under the influence of an electric field.<br />

The Product<br />

The device works by measuring biogenic amines that are present at elevated levels in infections and<br />

diseases, and returns a rapid accurate result. In the case of Bacterial Vaginosis the result is provided within<br />

one minute. In addition, the VGTest for BV spares the physician from having to perform the Amsel Test and<br />

“whiff tests” of vaginal fluid, or spend time waiting for laboratory Gram Stain results.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Distribution, R&D Funding<br />

Women’s health professionals, gynecologists, obstetricians, hospitals and health<br />

clinics<br />

Worldwide<br />

8


ACU Medical Technologies <strong>Israel</strong><br />

Back to TOC<br />

www.easylabour.com<br />

Company at a Glance<br />

ACU Medical Technologies develops and markets the patent-protected EasyLabour® device to bring comfort<br />

to women giving birth.<br />

EasyLabour is a non-invasive, drug-free way to alleviate labour pain by conveniently and comfortably<br />

applying pressure to specific acupressure points in the lower back. Launched after a successful clinical trial<br />

that demonstrated a dramatic decrease in labour pain, EasyLabour has been widely accepted and<br />

recommended by major medical centers and endorsed by obstetric professionals. ACU Medical<br />

Technologies is staffed by a team of seasoned experts in pain medicine, obstetrics, midwifery, medical device<br />

engineering, product design and electro-mechanical engineering.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment<br />

Obstetrics, Women's Health<br />

Initial Revenues<br />

Technology & Product(s)<br />

EasyLabour ® conveniently and comfortably applies acupressure to six specific acupressure points, three<br />

points on each side of the spine, on the sacral foramina of a woman during labour.A dedicated clinical trial to<br />

determine the level of pain relief experienced was conducted in the obstetrics department of a large medical<br />

center.<br />

The results indicated that continuous rotational pressure applied to the sacral area while using the selfoperated<br />

electro-mechanical device was found to significantly reduce labour pain within five minutes.<br />

Preliminary indications also suggest a shorter pain period during a contraction while using EasyLabour.<br />

EasyLabour ® is a CE mark, Class I device. Several hospitals are now using EasyLabour ® worldwide as a<br />

complementary pain relief alternative.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Find distribution channels, locate leading end-use customers<br />

Hospitals (private and public), private obstetric clinics, independent professionals<br />

involved in obstetrics<br />

Worldwide<br />

9


ALBAAD<br />

Back to TOC<br />

www.albaad.com www.albaad.com/generalPage.aspx?pageID=Pharma<br />

Company at a Glance<br />

Albaad is one of the three leading producers of wipes worldwide. As a fully integrated converter owning<br />

production facilities in Germany, the US and <strong>Israel</strong>, global R&D, regulatory and production teams, Albaad is a<br />

preferred partner for numerous renowned multinationals and retailers.<br />

We don’t just make wet wipes; we make it our business to know everything there is to know about them,<br />

constantly studying customer needs, market trends and technological innovations.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Disposable, Industrial OEM, Accessories<br />

General Health, Infection Control<br />

Initial Revenues<br />

Technology & Product(s)<br />

Albaad has invested in the development and registration of a range of products intended for professional<br />

and consumer healthcare use. Our products are registered as medical device class 2a, FDA and EPA where<br />

applicable. Albaad will have been accredited ISO 13485 medical standard for its pharma production lines by<br />

the end of 2010.<br />

The range includes several surface and medical device disinfectants, hand hygiene, patient care and bathing<br />

kits, adult incontinence wipes and several consumer solutions, including natural fever relief, jellyfish relief,<br />

hemorrhoids relief and antiseptic wipes.<br />

Albaad wipes are one-step ready for use wipes, tailored to meet our customers’ special needs and<br />

requirements. They are made with soft fabrics and impregnated with gentle yet effective liquids. The wipes<br />

are produced and tested according to stringent standards and inspected by strict quality assurance<br />

procedures.<br />

Goal<br />

Objectives:<br />

Seeking strategic partners to leverage R&D, regulatory and production capabilities for<br />

development and sales to professional, institutional and consumer healthcare<br />

markets in Europe and worldwide.<br />

Target Businesses: Professional, institutional and consumer healthcare<br />

Target Countries:<br />

EU, Worldwide<br />

10


Artisan Sonics Ltd.<br />

Back to TOC<br />

www.artisansonics.com/Eng<br />

Company at a Glance<br />

Artisan Sonics is an <strong>Israel</strong>i software house serving the medical community in <strong>Israel</strong> since 1996. Our<br />

customers include Hospitals, Public Health Providers and Private Clinics. We specialize in streamlining the<br />

work of OB&GYN ultrasound (US) practitioners and their supporting staff, where our distinct leadership is<br />

well established. The streamlining concept is implemented through continuous fieldwork and close<br />

collaboration with doctors and other medical personnel. Identified needs transform into applications that<br />

solve the needs, thus streamlining the working environment, saving time and money. Our innovative<br />

solutions are engineered to enhance care quality, reduce risk, assure compliance and overall to improve the<br />

quality of clinical management. Essentially, these features provide a positive health outcome for our<br />

customers' patients. The aforesaid results are achieved by a strict commitment to maintaining the highest<br />

standards of quality. Artisan Sonics is led by Dr. Yoram Alperovitch, who has an extensive background in<br />

medical devices and IT applications. Dr. Alperovitch is supported by a steering committee whose members<br />

are world-renowned practitioners in the area of OB&GYN ultrasound.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices, Healthcare IT<br />

Diagnostic, PACS Archiving, Internet-based Health Information<br />

Obstetrics, Women's Health<br />

Revenue Growth<br />

Technology & Product(s)<br />

(a) Archiver – The Archiver is our flagship product. It allows the OB&GYN ultrasound (US) practitioner to<br />

save long video recordings of images, to transfer measurements from the US, to print reports of different<br />

exams while using a US machine for obstetric or gynecological scans. It shortens the reporting and<br />

documentation process by 25 to 45 percent. This extensive software is based on a dot.net and C++ client.<br />

(b) Pregnancy Supervision Package (PSP) – A Web application based on Linux and PHP allowing its users to<br />

perform pregnancy supervision. Data from the Archiver is automatically integrated into the PSP.<br />

(c) Visit Scheduling – A Web application allowing the scheduling of visits and appointments. The list of daily<br />

scheduled patients is automatically transferred into the Archiver.<br />

(d) Billing – A Web application to allow automatic generation of visit/exam bills. The scheduled visit exam<br />

type and patient details are automatically incorporated into the bill.<br />

(e) Remote Facility Exams Archiving – C++ client and IPVPN and Web technology for exams data dual storage<br />

in two separate locations; The backed up exams can be viewed through the Internet.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

To find agents and distributors<br />

Medical equipment representatives and resellers.<br />

Europe and Asia<br />

11


Beth-El Zikhron Yaaqov Industries<br />

Back to TOC<br />

www.BEInd.com<br />

Company at a Glance<br />

Beth-El Zikhron Yaaqov Industries Ltd. is a leading developer and manufacturer of Medical Negative Pressure Isolation<br />

Systems and Collective NBC Filtration Systems. Drawing on more than 30 years of experience in the air filtration field,<br />

Beth El Industries now offers the medical market an array of stationary and portable isolation chambers, clean/sterile<br />

rooms and stand-alone air filtration systems for various applications in hospitals and ground or airborne ambulances.<br />

Our isolation chambers series – IsoArk® – is designed to quarantine infected people and protect the atmosphere<br />

outside the chamber from contagious diseases like SARS, Ebola and TB.<br />

The main advantages of these devices are:<br />

• Allow for a quick and effective isolation<br />

• Simple and fast assembly that requires no additional tools<br />

• Completely portable (solution can be brought to the problem)<br />

• Come in a variety of sizes and can be custom made according to our client’s requests<br />

• Cost only a fraction of the price of a permanent stationary isolation room<br />

Certifications:<br />

Beth-El Zikhron Yaaqov Industries Ltd. is certified for ISO 9001:2000, AQAP-2110 and AS 9100 quality management<br />

systems, and is audited regularly by external entities.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment<br />

Emergency Medicine, General Surgery, Infection Control, Infectious Diseases, Veterinary<br />

Revenue Growth<br />

Technology & Product(s)<br />

• IsoArk - portable, negative pressure chamber designed for a rapid set up of a biologically isolated environment, for<br />

quick and effective isolation of contagious people and equipment. The system includes an airlock attached to the main<br />

chamber and an air filtration system. Special features of this system enable treating the patient from the outside,<br />

avoiding contamination of equipment and staff. All of the system components meet and exceed today’s standards for<br />

airborne infection isolation, including the CDC guidelines for healthcare control.<br />

• IsoArk N36-2 - portable chamber designed for transporting a single person under isolated conditions. IsoArk N36-2<br />

fits on any standard stretcher, and is ideally suited for use in ground and airborne ambulances. IsoArk N36-2 is<br />

equipped with its own negative pressure filtration system, an “all around” zipper and integrated gloves and utility<br />

portals. With the battery fully charged, the system can operate for up to 10 hours independently of an external power<br />

source and guarantees a complete isolation of the space inside the chamber during transport. The “collapsible,”<br />

lightweight structure allows for a quick set up of the system and minimal storage requirements when not in use.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

1. Agent, able to promote the products to the medical and emergency preparedness sectors<br />

in his country. 2. Contact with potential end customers<br />

Government agencies in charge of emergency prepardness, hospitals, importers and<br />

distributors, health ministry, ambulance and ambulance equipment companies,<br />

airports.<br />

Worldwide<br />

12


B.R.F. Engineering Ltd.<br />

Back to TOC<br />

www.brf-eng.com<br />

Company at a Glance<br />

B.R.F. is a hi-tech company based in Nazareth Illit, <strong>Israel</strong>. It is a leading provider of comprehensive end-toend<br />

integrated outsourcing solutions for OEMs. B.R.F. designs, develops and manufactures complete<br />

packaged products and provides after-market services for its OEM customers.<br />

B.R.F. offers its innovative and integrated technologies of design, development and manufacturing<br />

supporting the company’s professional and social vision principles:<br />

• Facilitating and improving the customer's level of operations.<br />

• Lowering design and development costs.<br />

• Lowering production costs.<br />

• Reducing time to market (TTM).<br />

• Social responsibility.<br />

• Obtain, protect and leverage intellectual property rights to our designs.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Services<br />

Subcontractor, OEM, Robotics, Medical Equipment, Research Equipment<br />

Therapeutic Area(s):<br />

Company Status:<br />

Revenue Growth<br />

Technology & Product(s)<br />

• Machine design for the high-tech, bio-tech, microelectronics and food industries.<br />

• Electronic packaging design, starting from the initial setting, production file and product prototype.<br />

• Industrial machine design.<br />

• Mechanical guidance and backup ending with current production in short timetables.<br />

• Finite Elements Manufacturing Analysis (FEA).<br />

• Computer aided design services (CAD).<br />

• Technical writing (user manual including operational methods, assembly process and test procedures),<br />

and brochures.<br />

• In-house production.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Medical OEMs<br />

Medical OEMs<br />

Europe and America<br />

13


BSP Biological Signal Processing Ltd.<br />

Back to TOC<br />

Company at a Glance<br />

www.bspmedical.com<br />

Founded in 2000, BSP Biological Signal Processing Ltd. is a medical device company with corporate offices<br />

in Tel Aviv, <strong>Israel</strong> and a US subsidiary – BSP, Inc. – with sales and marketing offices in Rockville Maryland, US.<br />

BSP is publicly traded on the Tel Aviv Stock Exchange since 2006 (TASE:BSP).<br />

BSP develops and commercializes a new generation of systems for non invasive diagnosis and monitoring of<br />

Ischemic Heart Disease (IHD), based on advanced signal processing of the ECG signal which integrates the<br />

Company’s unique, patented, HyperQ technology.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Diagnostics<br />

Cardiovascular<br />

Initial Revenues<br />

Technology & Product(s)<br />

BSP has pioneered the clinical implementation of high-frequency ECG and has developed it into a fast,<br />

accurate, low-cost, simple to operate and non-radiating technology for detecting IHD with greater clinical<br />

value than the current standard ECG. The company’s proprietary HyperQ technology extracts and analyses<br />

the high-frequency components of the ECG and provides a unique diagnostic index. Thousands of patients<br />

have been tested with the HyperQ system to date, demonstrating consistently that HyperQ is far superior to<br />

conventional ECG both in sensitivity and specificity, with the potential to save up to 50% of the unnecessary<br />

radioactive imaging procedures, while improving the standard of care. BSP’s intellectual property portfolio is<br />

backed by four granted patents and 14 filed applications in different stages.<br />

HyperQ EX-300 Stress System: The HyperQ EX-300 Stress system enables an accurate and risk-free<br />

procedure for the early diagnosis of Ischemic Heart Disease (IHD). HyperQ stress testing is performed in a<br />

similar manner to a standard clinical stress test, providing the conventional stress ECG results, and the<br />

HyperQ test results, with extraordinary clinical accuracy. The system is offered as a combination of software<br />

and hardware that connects to a treadmill or stationary bicycle and constitutes a full ergometry (stress ECG)<br />

station that is FDA (510k) cleared and CE certified.<br />

Goal<br />

Objectives: The company’s primary strategic objectives include establishing HyperQ as the first line modality<br />

for monitoring and diagnosis of Ischemic Heart Disease in cardiology clinics, ambulatory and hospital<br />

settings, and attaining reimbursement code and premium coverage over competitors for the HyperQ<br />

diagnostic modality in the US. Growth in market penetration and market share will be achieved through a<br />

combination of business partnerships with equipment and healthcare service providers, and by the<br />

establishment of a global marketing and sales presence.<br />

Target Businesses: Distributors specializing in cardiovascular diagnostic devices, leading<br />

manufacturers in the field of cardiovascular diagnostic devices for potential business partnerships, leading<br />

health service providers.<br />

Target Countries:<br />

Worldwide<br />

14


C-Boot<br />

Back to TOC<br />

www.c-boot.com<br />

Company at a Glance<br />

C-Boot develops and manufactures advanced compression products for preventing and treating venous<br />

and lymphatic diseases and other conditions that require compression therapy, including DVT prevention.<br />

C-Boot offers the first intermittent pneumatic compression (IPC) line of products powered automatically by<br />

energy generated from the patient’s body.<br />

The company holds proprietary technological knowledge, patents covering the technological concept, and<br />

aspects in the field of low pressure compression.<br />

The first line of product is already generating revenues through sales to distributors. The company is now<br />

focused on expanding its worldwide presence.<br />

The manufacturing process is subject to stringent standards of quality assurance. All of C-Boot's products<br />

are FDA and CE approved, and the company has been granted the ISO 9001:2000 and ISO 13485:2003.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment<br />

Peripheral Vascular, Wound Care and Primary Care<br />

Initial Revenues<br />

Technology & Product(s)<br />

C-Boot’s patented system is a wearable sleeve comprising a unique pneumatic brain and several inflatable<br />

chambers that wrap the leg. Using the body’s own kinetic energy while an individual is walking, the system<br />

inflates the chambers in a gradient and sequential cycle which leads to blood release from both the<br />

superficial and deep veins. This strengthens the body's natural tendency to enhance lymphatic and venous<br />

return, and enables the blood to re-circulate toward the heart.<br />

C-Boot concept allows patients to maintain complete mobility without the need for cumbersome external<br />

pumps. The technology is protected by number of patents surrounding the use of kinetic energy to drive the<br />

pneumatic action, as well as the sophisticated internal mechanisms that allow for the pneumatic action to<br />

also be driven by a very small and portable compressor.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Distribution, Alliances<br />

Clinics, home care, orthopaedics and rehabilitation centers<br />

EU<br />

15


Cnoga Medical<br />

Back to TOC<br />

Company at a Glance<br />

www.cnoga.com<br />

Cnoga Medical is an innovative developer of easy-to-use, touch-free and non-invasive medical devices.<br />

Cnoga believes that the time is soon approaching when most blood tests will be conducted by the patients<br />

themselves, in the comfort of their own homes, and with a simple non-invasive device.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Monitoring<br />

Cardiovascular, Diabetics, Dermatology and Aesthetics, Hematology, Genetic<br />

Disorders, General Health<br />

Initial Revenues<br />

Technology & Product(s)<br />

Cnoga Medical’s technology provides a new patent pending and state of the art solution for the noninvasive/touch-free<br />

methods of measuring physiological parameters.<br />

Cnoga's technology is based on real-time tissue photography. Tissue image color is processed in real-time,<br />

providing temporary color distribution, using dynamic range of at least 36 color-depth representing over<br />

6.8^10 color combination. Then, by using a sophisticated mathematical algorithm, the vast amount of<br />

information is computed and analyzed for detecting the correlation between temporary color<br />

pigmentation and a specific bio or physiological parameter.<br />

Products:<br />

The Oximanometer – Pulse rate, blood pressure and SpO2 monitoring device<br />

The Hemoximeter – Hemoglobin, pulse rate, SpO2 monitoring device<br />

The Glucometer – Blood glucose, non-invasive, monitoring device<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Meet potential business partners and distributors, as well as potential customers<br />

Medical device distributors, hospitals and medical insurance companies<br />

EU<br />

16


Common Sense Ltd.<br />

Back to TOC<br />

Company at a Glance<br />

www.cs-commonsense.com<br />

COMMON Sense’s proprietary technologies enable the diagnosis of bacterial vaginosis (BV), trichomoniasis<br />

and amniotic fluid leakage through the non-invasive collection of vaginal secretions on panty–liners as well<br />

as on vaginal swabs.<br />

COMMON SENSE carries out R&D, manufactures and markets non-invasive OTC panty-liner home tests and<br />

OTC and OTC/Rx professional vaginal swabs for gynecologists, point of care and hospitals for the:<br />

1. Classification of common abnormal vaginal discharges and detection of acidity parameters associated<br />

with BV or trichomoniasis in symptomatic women.<br />

VI-SENSE (VI=Vaginal Infections) panty-liner and swabs kit<br />

2. Detection of amniotic fluid leakage.<br />

AL-SENSE (AL=Amniotic Leak) panty-liner kit<br />

3. Monitoring pregnant women with pre-term delivery history for asymptomatic BV infection and reduce<br />

risk of pre-term delivery.<br />

VA–Sense (VA=Vaginal Acidity) panty-liner kit<br />

4. Monitoring pH in asymptomatic women as an early warning for vaginal itching, odors and other<br />

symptoms.<br />

Norma-Sense panty- liner<br />

The company's inventions have been filed as US patents and PCT. The products are FDA and CE approved.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Diagnostic<br />

Gynecology, Women's Health<br />

Initial Revenues<br />

Technology & Product(s)<br />

COMMON SENSE Ltd.'s proprietary technology includes a range of indicator polymers that react with<br />

different pH levels, buffer capacity values, and ammonium ion concentrations by changing color from yellow<br />

to blue green, in the presence of vaginal secretions with elevated pH levels that indicate BV or trichomoniasis<br />

or an amniotic fluid leak.The resulting stain is stable for many hours, while the change in color due to the<br />

contact with urine is reversible.<br />

These kits providee, for the first time, the revolutionary ability to determine non-invasively the cause of<br />

abnormal vaginal discharge, and to identify amniotic fluid leakage. The company believes this technology to<br />

be applicable to a host of novel applications that until now have had no solution.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries: Worldwide<br />

COMMON SENSE Ltd.'s goal is to become the leading supplier of home and<br />

professional tests for common abnormal discharges, monitoring for abnormal pH<br />

levels, and detection of amniotic fluid leakage, as well as for other gynecological and<br />

urological conditions<br />

17


CoolSense Medical Ltd.<br />

Back to TOC<br />

Company at a Glance<br />

www.coolsense.net<br />

CoolSense Medical Ltd. is a subsidiary of the M.D. Clinic Group based in Tel Aviv, <strong>Israel</strong>; an established and<br />

prestigious medical health center whose specialty in non-surgical aesthetic procedures serves an extensive<br />

network of cosmetic treatment clinics.<br />

CoolSense Medical Ltd. was responsible for the R&D that preceded the manufacture of the innovative handheld<br />

CoolSense pain numbing applicator. CoolSense's successfully implemented concept offers medical<br />

personnel, aestheticians and the general public a revolutionary but simply operated instrument that<br />

eliminates the pain and discomfort of injection procedures. The CoolSense Pain Numbing Applicator,<br />

which has received CE approval, FDA certification, and the <strong>Israel</strong>i Certificate of Free Sale is in use worldwide.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment<br />

Diabetics, Dermatology, Aesthetics, Endocrinology, General Health, Nephrology<br />

Initial Revenues<br />

Technology & Product(s)<br />

The innovative CoolSense device, when applied to the skin immediately, anesthetizes the site of injection<br />

with no after effects. The CoolSense Pain-Free Injection Applicator has been accepted as an indispensable<br />

instrument for health care personnel when performing medical or cosmetic skin invasive procedures. The<br />

CoolSense Applicator is also an invaluable tool that greatly improves the quality of life for individuals who<br />

are obliged to undergo injection procedures on a daily basis.<br />

CoolSense acts within 3-5 seconds to do away with the stress and fear that is associated with receiving<br />

injections, the most common health-care procedure worldwide.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Finding potential distributors for main European countries.<br />

Distributors<br />

Germany, France, Switzerland, UK<br />

18


EarlySense Ltd.<br />

Back to TOC<br />

www.earlysense.com<br />

Company at a Glance<br />

EarlySense Ltd. is bringing to market the EverOn system, an automatic, continuous, contact-free patient<br />

monitoring system that accurately identifies high-risk patient conditions. Alerting caregivers immediately<br />

upon detecting such events enables earlier interventions, leading to reduced complications and costs.<br />

EarlySense is headquartered in Ramat Gan, <strong>Israel</strong> and employs a multi-disciplinary team of 25 engineers,<br />

physicists, physicians, nurses and marketing professionals working closely with clinical sites worldwide. The<br />

Company’s vision is that within 10 years, all acute, chronic and geriatric patients will be continuously<br />

safeguarded with such continuous monitoring solutions in home and hospital settings.<br />

EarlySense's EverOn system bridges the critical time gap between patient deterioration and clinician<br />

intervention. In light of the Joint Commission’s 2009 Patient Safety Goals for healthcare organizations,<br />

EarlySense's technology offers a timely solution for detecting changes in a patient’s condition, while also<br />

helping nurses focus on the patients who need their immediate attention.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment, Monitoring<br />

General Health<br />

Initial Revenues<br />

Technology & Product(s)<br />

Technology<br />

EarlySense's technology is based on advanced signal-processing algorithms developed and refined over<br />

years of extensive in-vivo testing. The patented systems include ultra-sensitive components that monitor<br />

patients without direct contact or the need for patient compliance. The algorithms enable clinically accurate<br />

tracking and measurement of respiration and heart rates, as well as patient movement, including bed<br />

entry/exit and patient turn verification as indicated by a nurse interface.<br />

Automatic System Operation<br />

EarlySense’s technology has three main components: 1) a unique single plate sensing unit; 2) a bedside unit<br />

that processes and displays the measured data; and 3) a central station display that enables complete<br />

coverage of a unit wide set of monitors at a single point and enables an interface to the nurses’ mobile<br />

devices. Once placed under a bed mattress, the sensing unit immediately self-activates whenever the patient<br />

is in bed. The continuously filtered, sampled and analyzed data can be stored, and if desired can be printed<br />

for documentation and clinician analysis. The system is FDA and CE cleared and has been shown to improve<br />

clinical outcomes in general care units.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

To be a market leader in the Medical Supervision Field<br />

Sales in USA, major clinical study at Harvard/leading university<br />

USA, the Netherlands, Italy and Germany<br />

19


Elitr Advanced Systems Ltd.<br />

Back to TOC<br />

Company at a Glance<br />

www.elitr.com<br />

Elitr Advanced Systems Ltd. is a medical device company founded in <strong>Israel</strong> in 2005. The company’s mission is<br />

to offer a full range of non-invasive, multi-parameter patient monitoring devices and health management<br />

software tools to the full satisfaction of its customers and end-users.<br />

Elitr stations can be used for preventive screening for emergency room of national hospitals<br />

Elitr develops and manufactures distinct and innovative products hardware and software.<br />

The company's unique approach encourages the adoption of a preventative medicine and healthy lifestyle by<br />

simplifying the diagnosis and implementation processes by health stations, both of the individual and for the<br />

accompanying professionals.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices, Healthcare IT<br />

Diagnostic, Monitoring, Telemedicine, SW & HW, Biometrics<br />

Primary Care, General Health, Cardiovascular, Diabetics, Obesity<br />

Initial Revenues<br />

Technology & Product(s)<br />

Elitr provides: health station, specially designed to meet the needs of individuals and organizations that<br />

either wish to cut down their costs (e.g. hospitals and retirement homes), to increase their profits (e.g.<br />

pharmacy chains and gyms), or to improve their health and nutrition management.<br />

The health station provides gold standard measurement of some or all of the following vital signs: height,<br />

weight, BMI (Body Mass Index), RMR (Resting Metabolic Rate), hand grip strength test, body composition,<br />

blood pressure, pulse rate, electrical activity of the heart (EKG), heart rhythm regularity oxygen saturation,<br />

body temperature – all through a quick, non-invasive, single-posture process.<br />

In addition, they can be complemented by external monitoring devices.<br />

Elitr’s health station are automatically subscribed to the complementary health and weight management<br />

software BioFat, and can be subscribed to any other external database, including electronic medical records<br />

(EMRs). Telehealth MultiNurse, Elitr's most advanced health station model, also includes video conferencing<br />

and other telecommunications features, and it can also be compatible with the medical magnetic or smart<br />

card.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

To establish a worldwide distribution network, joint ventures with customers or<br />

distributors of diagnostic devices, health insurance companies<br />

Hospitals, private clinics, medical devices distributors, health spa channels,<br />

pharmacies<br />

Europe, Asia, North Africa, Middle East<br />

20


Elmedical Ltd.<br />

Back to TOC<br />

Company at a Glance<br />

www.elmedical.co.il<br />

Elmedical offers practical and better solutions for two unmet urological diseases: non-muscle invasive<br />

bladder cancer (NMIBC) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). In both diseases,<br />

other emerging thermal treatments already showed proof of concept and resulted in multiple procedures<br />

for each patient over the years. NMIBC and CP/CPPS are treated successfully by the company's office-based<br />

system (compact console and disposable catheters), which is approved in Europe and <strong>Israel</strong> as a urological<br />

thermal treatment platform. Elmedical's innovative solutions in these diseases offer superior clinical results<br />

and better economics.<br />

In the future, the company's platform plans to cover two more unmet urological diseases: overactive bladder<br />

(OAB) and interstitial cystitis/bladder pain syndrome (IC/BPS). In addition, Elmedical is aiming for its "hot<br />

urology solutions" to become the market preferred solutions in the four unmet diseases.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Minimally Invasive Systems<br />

Urology, Gynecology, Oncology<br />

Initial Revenues<br />

Technology & Product(s)<br />

Elmedical's proprietary non-ablative high temperature innovative technologies UniThermia and DuoThermia,<br />

covered by issued and pending patents, have clear and unique advantages over the other emerging thermal<br />

treatments in NMIBC and CP/CPPS.<br />

The company's BWT (Bladder Wall Thermochemotherapy) treats NMIBC with uniform hyperthermia<br />

(UniThermia) all over the bladder with a high flow of a heated chemotherapy solution. The BWT powerful<br />

heat-chemotherapy synergy is very effective and has practically no adverse events.<br />

DuoThermia provides simultaneous thermal treatments to the prostate (by a heated balloon) and bladder<br />

(by a heated saline circulation) to treat CP/CPPS where it prevails, the prostate and bladder, with dedicated<br />

heat sources and the other pelvic organs with the heated blood perfusion.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

To find a strategic partner and/or national distributors, established in urology, to<br />

market and sell the company's unique technology worldwide<br />

Cooperation with a strategic partner/distributors to develop the market in the<br />

unmet urological diseases and to support the clinical and regulatory processes in<br />

various countries<br />

Europe, <strong>South</strong> America, Asia and the US<br />

21


ElsMed Medical Systems Ltd.<br />

Back to TOC<br />

www.elsmed.com<br />

Company at a Glance<br />

ElsMed is a worldwide medical equipment supplier with extensive experience and known for high quality,<br />

fully refurbished diagnostic imaging medical equipment at an affordable price point. We have built our<br />

reputation for being the most trusted professional source for top quality and reliable equipment, service,<br />

parts and technical support.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Diagnostic, Imaging, Training, Medical Equipment<br />

General Health<br />

Revenue Growth<br />

Technology & Product(s)<br />

Our capabilities range from providing completely refurbished medical equipment, supplying all spare parts<br />

and ongoing service with extremely fast response time and On-Line Remote-Diagnostic support in real time.<br />

Our services range from initial consultation and evaluation, to complete turn-key projects for all diagnostic<br />

imaging centers and hospitals. Our staff includes the most experienced field engineers and factory trained<br />

support specialists for CT, MRI, NM, PET, Ultrasound and other technologically advanced systems.<br />

We service and support over 150 systems worldwide. ElsMed will be your first partner in providing low-cost,<br />

high-end medical equipment and service to any imaging diagnostic centers worldwide.<br />

Products:<br />

• Computer Tomography Systems<br />

• Nuclear Medicine Systems<br />

• MRI<br />

• ULS<br />

• NM Diagnostic Workstation<br />

• CT Diagnostic Workstation<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Looking for dealers of refurbished medical equipment and turn-key projects for<br />

medical venters<br />

Medical Imaging<br />

Worldwide<br />

22


Erika Carmel Ltd.<br />

Back to TOC<br />

www.gd-energies.com<br />

Company at a Glance<br />

As a company whose goal is to bring innovations in treatment, care, and quality of life to more and more<br />

people, we are proud to present you with cutting edge technology in soft laser therapy: B-Cure Laser is the<br />

world's first portable soft laser medical device WITH THE HEALING POWER OF A CLINIC.<br />

B-CURE Laser is recommended by the best pain specialists and is used widely in <strong>Israel</strong> by the leading pain<br />

clinics, wound healing clinics, and orthopedic departments in the following hospitals: Hadassah-Jerusalem,<br />

Sourasky, Rambam, and Sheba (Tel Hashomer). It is also used by the physiotherapy clinics of <strong>Israel</strong> Defense<br />

Force, leading sports clubs, and the best sportsmen in <strong>Israel</strong>, as well as by thousands of individuals for selftreatments<br />

at home.<br />

On January 2010 B-Cure Laser received the European CE 0120 approval for 16 indications and is presently<br />

being exported to some European countries.<br />

CE 0120 approved indications of B-Cure Laser are: knee pain, pain in neck, lower and upper back, sports<br />

injuries, muscle pain, arthritis, fibromyalgia, tennis elbow, Achilles tendonitis, carpal tunnel syndrome,<br />

inflammation, wound healing, burns, fresh surgical scars, post-pregnancy stretch marks, acne, herpes<br />

simplex, dental medicine, acupuncture.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment<br />

Orthopedic, Wound and Pain Management, Dermatology, Rehabilitation<br />

Revenue Growth<br />

Technology & Product(s)<br />

B-Cure Laser- LLLT 808- Low Level Laser Treatment<br />

The soft-laser effects the skin’s surface and simultaneously penetrates the skin without heating or hurting<br />

the skin.<br />

Soft laser treatment biostimulates the body’s natural healing mechanisms on a cellular and systemic level.<br />

The result: each kind of cell receives the energy required for activation of its optimal functioning in the body,<br />

thus allowing it to “self-heal” and naturally overcome specific problems.<br />

B-CURE LASER - an international breakthrough in soft laser therapy for professional and personal treatment<br />

of the aforesaid indications.<br />

Thanks to an exclusive, patent-pending development, we have created an exceptional combination: the<br />

power and full coherence of a clinic's soft laser device over a large area of 4.5 cm², with a portable,<br />

rechargeable, safe and easy-to-use device – all at a reasonable price.<br />

The result: a perfect combination of the most effective therapy with the ability to provide immediate and<br />

continuous treatments, thus enabling high quality and fast recovery in shorter individual treatment times,<br />

and with less total healing time.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Distribution<br />

Clinics, hospitals, sports teams, athletes, security forces, home care, nursing homes,<br />

and individuals for self-treatment at home.<br />

EU, USA, <strong>South</strong> America, Australia<br />

23


ETView<br />

Back to TOC<br />

www.etview.com<br />

Company at a Glance<br />

ETView manufactures the Tracheoscopic Ventilation Tube (TVT), an endotracheal tube fitted with a camera<br />

and light source for continuous monitoring of the airways.<br />

The TVT is the ideal tube for airway management, as it reduces the occurrences of difficult intubation while<br />

providing hospitals with a 100% verification of tube location and pinpointed suctioning of secretion<br />

buildup. By allowing for continous viewing of the airway, the TVT can minimize the amount of patient X-rays<br />

and should significantly reduce instance of VAP.<br />

The TVT is also sold as a trainer, and is the ideal device for teaching and refreshing intubation skills to<br />

medical students and emergency personnel.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Disposable<br />

Emergency Medicine, General Surgery, Intensive Care, Respiratory<br />

Revenue Growth<br />

Technology & Product(s)<br />

ETView’s patented, single-use tracheoscopic ventilation tube (TVT) incorporates a video camera and light<br />

source embedded in the tip of a conventional ventilation tube. The images from the TVT can be viewed on<br />

ETView's dedicated monitors, or on other monitors/computers.<br />

With a camera at this critical location, medical personnel can effectively monitor, identify, and perform<br />

suction on the buildup of secretions in both lungs, thereby significantly minimizing the risk of ventilatorassociated<br />

pneumonia.<br />

The TVT is indicated for use in the ICU, OR, ER and pre-hospital.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

To find distributors that will sell the TVT in their respective markets<br />

Distributors<br />

Worldwide<br />

24


First Care Products<br />

Back to TOC<br />

Company at a Glance<br />

www.firstcareproducts.com<br />

First Care Products specializes in the development and marketing of new products for pre-hospital<br />

emergency medical situations. The company's mission is to provide intelligent, innovative, effective and<br />

simple to use products which assist in life-saving, improve the treatment provided and yield significant<br />

savings in time and resources.<br />

Save One Life, Save A World<br />

Active in medical R&D, the company develops beneficial solutions for pre-hospital medical emergencies. First<br />

Care Products provides medics, first responders and the injured themselves with easy and quick to use,<br />

effective products for the control of hemmorhage resulting from trauma that save lives and greatly boost<br />

the treatment provided, whether on the battlefield, home front or accident scene. The company brings its<br />

years of comprehensive R&D and field experience to create products that, when every second counts, make<br />

the difference between life and tragedy.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Disposables<br />

Emergency Medicine<br />

Revenue Growth<br />

Technology & Product(s)<br />

The Emergency Bandage<br />

First Care Products' first and flagship product, The Emergency Bandage in all its versions has been<br />

designated as the "STANDARD" Personal Field Dressing by numerous major, quality military organizations,<br />

and is used by Special Forces and military medical corps worldwide. The Emergency Bandage is combat and<br />

clinically proven, being relied upon as an integral and vital component in the treatment of hemorrhage and<br />

trauma-related injuries.<br />

Beyond Military Use<br />

In addition to militaries around the world, First Care Products supplies its innovative bandages to<br />

governmental and private emergency medical services, Fire and Rescue, Police and Prison Authorities, First<br />

Aid and Survival Academies, and suppliers of first aid equipment to the general public.<br />

Worldwide Patent and Approvals<br />

First Care Products' bandages are patented worldwide, FDA and CE Approved, with health ministry approvals<br />

in each territory, NATO Reference Numbers, and NSNs in the USA. First Care Products manufactures all its<br />

products according to the highest International standards, including ISO 13485.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Strategic Alliances<br />

Worldwide<br />

25


Flexicath<br />

Back to TOC<br />

www.flexicath.com<br />

Company at a Glance<br />

Flexicath developed and market breakthrough catheter insertion systems to ensure simple, safe, and sterile<br />

intravenous catheterization.<br />

Addressing the need for a safe, easy-to-insert catheter for up to a 29-day treatment period, Flexicath has<br />

developed the M/29, a technology that combines a 30-day indweller IV catheter with special designed OTN<br />

introducers and an innovative 360 maximum barrier self-enclosed design to allow completely sterile<br />

insertion systems that are:<br />

• Safer and reduce risk of contact or airborne infections<br />

• Easier to use<br />

• More cost-effective, and do not require an external sterile environment<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Disposable, Implantable<br />

Hematology, Intensive Care, Internal Medicine, Oncology, Orthopedic, Pediatrics,<br />

Peripheral Vascular<br />

Initial Revenues<br />

Technology & Product(s)<br />

The M/29 combines a standard PICC line-type catheter that is completely enclosed in a sterile silicon sleeve<br />

and PeelGuard, a special silicone insertion unit. The sleeve creates a self-contained, sterile insertion field<br />

to form a 3D 360 maximum barrier.<br />

This design has several advantages:<br />

• Throughout the insertion procedure the catheter is fully encased and prevents touch and airborne<br />

contamination.<br />

• The system virtually eliminates blood backflow.<br />

• The insertion procedure is safe, simple, can be done by a floor nurse and is cost effective.<br />

• The M/29 has IV dwell time of up to 29 days<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Distribution, Alliances<br />

Industry leaders, manufacturers<br />

Germany, France, UK, Italy, Spain, <strong>South</strong> Africa, Australia<br />

26


Flight Medical<br />

Back to TOC<br />

www.flight-medical.com<br />

Company at a Glance<br />

Established in 1996, Flight Medical specializes in the development, manufacturing and marketing of<br />

respiratory life supporting equipment. Since its inception, Flight Medical had been focused on the high end of<br />

the portable ventilators market.<br />

Flight Medical develops and manufactures the HT50 (marketed worldwide exclusively by Newport Medical<br />

Instruments, Inc.), and its newly introduced Flight 60, both incorporating Flight Medical’s proprietary<br />

technology.<br />

To date over 12,000 Flight Medical ventilators have been helping patients worldwide, winning their<br />

reputation as a truly reliable, feature-loaded yet easy and intuitive to use portable ventilator.<br />

Flight Medical is a public company listed on the Tel Aviv Stock Exchange, with offices located in Lod, <strong>Israel</strong>.<br />

Flight Medical is a subsidiary of Medtechnica, <strong>Israel</strong>’s largest distributor of medical equipment.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment<br />

Emergency Medicine, Intensive Care, Primary Care, Pulmonary, Rehabilitation,<br />

Respiratory<br />

Revenue Growth<br />

Technology & Product(s)<br />

Flight Medical, the developer and manufacturer of the HT50 ventilator, which has been successfully used in a<br />

broad range of applications for over 10 years, is now offering an opportunity to participate in the launch of<br />

its new Flight 60 ventilator. Designed to continue the success of the 12,000 Flight Medical HT50 ventilators<br />

operating mainly in the United States and Japan, the newly introduced Flight 60 Ventilator offers even more:<br />

• Improved ventilation modes<br />

• Exhalation volume measurement<br />

• An intuitive 7" touch screen interface<br />

• 12 hours of battery life. Hot Swap capability provides practically unlimited independence<br />

• External communications<br />

The Flight 60 ventilator is a perfect fit for Home Care, Long Term Care, Transport and Hospitals<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Establish distribution network for our Flight 60 ventilator throughout the world.<br />

Distributors of medical devices, calling on Home Care, Long Term Care, Transport and<br />

Hospitals.<br />

Worldwide<br />

27


Haldor Advanced Technologies Ltd.<br />

Back to TOC<br />

www.haldor-tech.com<br />

Company at a Glance<br />

Haldor Advanced Technologies Ltd. specializes in integrating technological solutions that meet the business<br />

needs of the healthcare industry.<br />

The company was founded with a declared purpose to enhance surgical procedures with safe and efficient<br />

technological systems that will benefit doctors, surgeons, hospitals and, most importantly, patients.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment<br />

General Surgery<br />

Initial Revenues<br />

Technology & Product(s)<br />

ORLocate is an RFID-based system that counts, monitors, and tracks surgical instruments and sponges.<br />

ORLocate was designed to change the way Operating Rooms around the world perform counts and<br />

manage their assets. It is the first RFID technology system of its kind that offers an all-encompassing solution<br />

with automated counting and advanced tracking features that significantly enhance patient safety and<br />

maximize overall productivity and yield of hospitals, doctors and nurses.<br />

Human-related errors are attributed to faulty counting systems and negligible tracking procedures that are<br />

costing the United States healthcare industry over $2 billion annually. ORLocate offers hospitals a<br />

business opportunity to tap into long-term revenue schemes with a high Return on Investment while<br />

focusing on the highest industry standards for patient safety.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Seeking strategic marketing partner in Europe and <strong>South</strong>east Asia<br />

EMEA and SEA<br />

28


Hanita Lenses<br />

Back to TOC<br />

www.hanitalenses.com<br />

Company at a Glance<br />

Established in 1981, Hanita Lenses is <strong>Israel</strong>'s market leader and foremost manufacturer of Intraocular Lenses<br />

and Contact Lenses, with more than 60% of the local market.<br />

Hanita’s strategy focuses on innovation in R&D and technology, in order to maintain the company as a<br />

dynamic leading player in the ophthalmic medical device market.<br />

Hanita’s products are sold through a network of distributors throughout Europe, Asia, Latin America, and<br />

elsewhere.<br />

Lenses manufactured by Hanita Lenses meet the highest quality standard required by the European Union<br />

and carry the mark of approval:<br />

• European CE Mark<br />

• ISO 13485:2003 Medical Device Quality System<br />

• ISO 9001: 2000 Quality Systems<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Disposable, Implantable<br />

Ophthalmology<br />

Revenue Growth<br />

Technology & Product(s)<br />

Intraocular Lenses:<br />

Investments in stage-of-the-art equipment and technology, both in R&D and production, have placed Hanita<br />

in a leading position, enabling the company to compete in the fast-changing IOL market.<br />

New, advanced products are continually in the R&D pipeline. Hanita’s highly skilled team works in close<br />

collaboration with the company’s advisory board, comprising leading ophthalmic surgeons, and led by Prof.<br />

Ehud Asia.<br />

This collaboration allows the company to develop innovative intraocular lense designs that support new<br />

surgical techniques.<br />

Contact Lenses:<br />

Hanita Lenses manufactures and sells a broad range of GP, soft, conventional, special and disposable<br />

contact lenses, using the most advanced raw materials. Special designs, such as Toric Lenses, Keratoconus,<br />

Orthokeratology and lenses for dry eyes, are included in the range.<br />

The latest computerized techniques, as well as the state-of-the-art equipment, contribute to the excellence<br />

of our contact lens division.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Finding sutable distributors for Hanita Lenses products<br />

Opthalmic market, specifically the cataract field<br />

Europe - UK, Germany, Ireland, the Netherlands, Belgium, Spain, Scandinavia, Eastern<br />

Europe, Turkey, <strong>South</strong> Korea and Asia-Pacific<br />

29


HypnoCore Ltd.<br />

Back to TOC<br />

www.hypnocore.com<br />

Company at a Glance<br />

HypnoCore Ltd. was founded in 2006 with the vision of developing new methods to detect sleep disorders.<br />

The company was formed following over 10 years of successful academic collaboration between the<br />

founders, resulting in a technological breakthrough that has become the company's core technology.<br />

Mission Statement: HypnoCore is an innovative leader in the wellness and healthcare industries, and has<br />

revolutionized the field of sleep medicine by providing reliable, cost effective and user friendly sleep<br />

diagnostic solutions for home use that will help facilitate the treatment of chronic conditions and elevate the<br />

general quality of life.<br />

Medical Market Status:<br />

• CE, FDA approvals in 2008<br />

• Medical market services launched in Germany and <strong>Israel</strong> in 2010<br />

• Patent approved<br />

• Cooperation with leading <strong>Israel</strong>i corporate wellness companies<br />

• Consumer Business Status:•Full integration underway with Polar and Suunto heart rate monitors<br />

• Cooperation with Suunto in the wellness market<br />

• Research cooperation with Polar<br />

• Cooperation with the Wingate Institute - <strong>Israel</strong>'s leading sports institution<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Medical Devices<br />

Subcategory: Diagnostic, Monitoring, Telemedicine, Research Equipment, Training, SW & HW<br />

Therapeutic Area(s):<br />

Company Status:<br />

Technology & Product(s)<br />

Cardiovascular, Dental, Ear, Nose and Throat, General Health, Obesity, Primary Care,<br />

Respiratory<br />

Regulatory Approval<br />

In the medical market, HypnoCore technology enables the convenient collection of ECG data in people's<br />

homes and provides sleep laboratories with the opportunity for unlimited virtual expansion. With<br />

HypnoCore’s solutions, sleep laboratories and medical practitioners can expand their patient load to include<br />

multiple out-patients who simply send and receive their results and diagnosis over the web at a fraction of<br />

the cost of conventional in-patient procedures. The upgrade in the entire process will enable medical<br />

institutions to expand their patient populations without incurring major expenses.<br />

In the wellness and consumer healthcare market, HypnoCore technology will allow the average person to<br />

evaluate and improve his sleep on his own. In the initial stages, HypnoCore will offer a web application for<br />

sleep analysis and a guide on how to improve sleep, for heart rate monitor users of the most popular brands<br />

such as Polar, Suunto, Garmin, and others. These users are generally sportsmen, athletes and people<br />

independently seeking solutions or striving to improve their health and wellness.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Strategic Alliances<br />

Worldwide<br />

30


Intromedix<br />

Back to TOC<br />

www.intromedix.com<br />

Company at a Glance<br />

Intromedix is an <strong>Israel</strong>i manufacturer of premium quality, cost-effective, generic, disposable surgical<br />

equipment.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Disposable, Implantable, Medical Equipment<br />

General Surgery<br />

Revenue Growth<br />

Technology & Product(s)<br />

Surgical Sutures - absorbable and non-absorbable<br />

Surgical Staplers<br />

Skin Staplers<br />

Surgical Mesh<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Establish partnerships for distributing our products in key European countries.<br />

Distributors<br />

All European countries<br />

31


Itamar Medical<br />

Back to TOC<br />

Company at a Glance<br />

www.Itamar-Medical.com<br />

Itamar Medical Ltd. is a public traded (TASE: ITMR) bio-medical technology company. Itamar develops and<br />

markets noninvasive diagnostic medical equipment based on the proprietary PAT (Peripheral Arterial<br />

Tone) Signal. The PAT Signal serves as a noninvasive window to the Cardiovascular and Autonomic<br />

Nervous Systems.<br />

The PAT Signal is acquired by measuring pulsatile arterial volume changes in the fingertip by specialized<br />

noninvasive probes. Itamar’s FDA cleared and CE marked PAT-based products include:<br />

• Endo-PAT2000: noninvasive, office-based, user-independent device for endothelial function<br />

assessment – the precursor (earliest clinically detectable stage) of cardiovascular disease.<br />

• Watch-PAT200: ambulatory diagnosis of sleep-related breathing disorders and sleep staging<br />

(Wake/REM/Deep Sleep/Light Sleep stages).<br />

Both devices are used in preeminent clinical institutions, research centers and pharmaceutical clinical phase<br />

studies in over 40 countries, which have yielded nearly 300 publications.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Diagnostic<br />

Cardiovascular, Dental, Ear Nose and Throat (ENT), General Health, Internal Medicine,<br />

Neurology and Degenerative Disease, Peripheral Vascular, Primary Care, Respiratory<br />

Revenue Growth<br />

Technology & Product(s)<br />

Sleep testing - at home<br />

Considered “best in class,” WatchPAT (FDA cleared and CE marked) is a wrist mounted device for at-home<br />

testing of sleep apneas and sleep staging (REM/Deep Sleep/Light Sleep/Wake stages). WatchPAT also<br />

measures snoring & body position and provides a perfect combination of natural sleep at home with sleeplab<br />

level data.<br />

WatchPAT works without the multiple cables and electrodes needed by other technologies that provide indepth<br />

analysis of sleep, so it has an incredibly low failure rate. Yet the physician gets a comprehensive report<br />

with all the clinical parameters needed for patient treatment and monitoring. While the data are calculated<br />

automatically by the WatchPAT’s software, the physician can easily edit the data as well.<br />

Noninvasive cardiovascular risk assessment<br />

Atherosclerosis is the clinical manifestation of endothelial dysfunction. Leading the field of endothelial<br />

function assessment, EndoPAT (FDA cleared and CE marked) is used in pre-eminent clinical institutions,<br />

research centers and Pharma studies. The noninvasive EndoPAT has been validated by nearly 100<br />

publications and abstracts, and it provides clinicians with reliable and reproducible results in a 15-minute,<br />

office-based test.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Establish wide distribution network in Europe<br />

Distribution<br />

Brazil, Germany, UK, Spain, France<br />

32


Medical Market Bridge Ltd.<br />

Back to TOC<br />

www.mmbim.com<br />

Company at a Glance<br />

Medical Market Bridge (MMB) is an international marketing and business development company that acts as<br />

a bridge for medical device companies and rapidly brings innovative technologies to market success. MMB is<br />

actively present in a vast range of international medical device markets.<br />

MMB specializes in creating and managing revenue making sales channels for medical device companies.<br />

Each member of our group of 13 medical device experts is situated in his home country, where he has the<br />

experience and contacts to enable smooth market entry.<br />

MMB covers Europe, Pacific and Latin America.<br />

What do we do for our clients? For each manufacturing client, we match the best suited distributor, from a<br />

database of thousands. This important stage in the commercial lifecycle is done according to marketing<br />

strategy and local market characteristics. We strive to achieve a solid distribution agreement and manage<br />

the commercial interaction between the parties, being the manufacturer marketing office in each country.<br />

Low risk unique compensation model - MMB fees are success dependent. This means that our clients pay us<br />

only once real commercial activity has started.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Services<br />

Business Development<br />

Revenue Growth<br />

Technology & Product(s)<br />

MMB at Medica – B2B<br />

Our open booth at Medica will host B2B meetings, where manufacturers and distributors will discuss<br />

business collaboration.<br />

This is a great opportunity for creating new business partnerships.<br />

We invite manufacturers to participate in our B2B program, and make Medica an effective event.<br />

Distributors are also invited to contact us and see what we can offer to add to their product line.<br />

MMB represents several innovative technologies seeking distribution partners from Europe, Asia- Pacific<br />

region and Latin America.<br />

We are always glad to meet distribution companies and present our technologies to them.<br />

Currently, we offer technologies in Surgery, Urology, Gynecology, Orthopedics, Pain Management, Oncology,<br />

Anesthesia, Cardiology, Vascular Aurgery and more.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

MMB creates face to face meetings between manufacturers and distributors, and<br />

represents our current technologies<br />

Manufacturers and distributors of medical devices<br />

Worldwide<br />

33


MediTouch<br />

Back to TOC<br />

www.meditouch.co.il<br />

Company at a Glance<br />

MediTouch manufactures and sells innovative upper and lower limb active exercise systems with<br />

biofeedback trainers. The rehabiliation systems consist of gloves, elbow and leg braces, as well as dedicated<br />

rehabilitation software. The systems are designed to help patients recovering from stroke, traumatic brain<br />

injury, multiple sclerosis, cerebral palsy and incomplete spinal cord injury regain hand and leg movement.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment, Telemedicine, Training<br />

Cardiovascular, Neurology and Degenerative Disease, Pediatrics, Orthopedic,<br />

Primary Care, Rehabilitation<br />

Revenue Growth<br />

Technology & Product(s)<br />

HandTutor, ElbowTutor, LegTutor, AnkleTutor<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Looking to establish a wide distribution network<br />

Distributors<br />

Worldwide<br />

34


Medoc Ltd.<br />

Back to TOC<br />

www.medoc-web.com<br />

Company at a Glance<br />

Medoc is a leading manufacturer of neuro-diagnostic medical systems and advanced thermal stimulators<br />

for the assessment of chronic pain. Medoc's products evaluate the small and large peripheral sensory nerve<br />

fibers (A-delta and C fibers), constituting the "Pain Pathway."<br />

In 2006, Medoc established the Medoc <strong>Israel</strong> Division. This division represents companies worldwide,<br />

promoting and distributing their advanced medical solutions to the <strong>Israel</strong>i market. Medoc Ltd. has developed<br />

several strategic collaborations with leading international suppliers from the USA and Europe, including<br />

Boston Scientific, for treating severe and chronic pain patients by implanting advanced spinal cord<br />

stimulation (SCS) device, Neurotherm for treatment of local pain by applying Radio Frequency (RF) directly to<br />

the pain source, Epimed for nerve block solutions and catheters and HydroCision for minimal invasive<br />

discectomy.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Diagnostic<br />

Neurology and Degenerative Disease, Pain Management<br />

Revenue Growth<br />

Technology & Product(s)<br />

The PATHWAY Pain and Sensory Evaluation System offers new applications for advanced pain research and<br />

fMRI. The PATHWAY model CHEPS (Contact Heat-Evoked Potential Stimulator) marks a breakthrough in the<br />

field of pain-evoked potential, allowing objective assessment of evoked pain. The PATHWAY model ATS<br />

(Advanced Thermal Stimulator) and PATHWAY model CHEPS are currently used in fMRI studies and in<br />

advanced pain research.<br />

The TSA-II Thermal Sensory Analyzer is used in QST (Quantitative Sensory Testing) to clinically evaluate small<br />

nerve fibers (A-delta and C fibers). The VSA-3000 Vibratory Sensory Analyzer is used in the assessment of<br />

large peripheral nerve fibers (A-beta).<br />

The recently launched Computerized Algometer is a new software-based system, providing real-time visual<br />

and auditory feedback to control and monitor applied pressure rates.<br />

Medoc is also interested in expanding its scope of products in the <strong>Israel</strong>i market by signing partnership<br />

agreements with promising medical device companies offering breakthrough technology and innovative<br />

products.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Looking for representatives/distributors. Medoc is also interested in expanding its<br />

scope of products (for the <strong>Israel</strong>i market only), and in signing exclusive distribution<br />

agreements with promising non-<strong>Israel</strong>i medical device companies offering<br />

breakthrough technology and innovative products.<br />

Distributors; Medical device companies offering breakthrough technologies<br />

Distributors in China, Portugal, India. Medical device companies worldwide.<br />

35


Mizra Medical<br />

Back to TOC<br />

www.mizramedical.com<br />

Company at a Glance<br />

Mizra Medical Ltd. developed out of a family business, Mizra Latex Products, founded by Mr. Zeev Mizra in<br />

1955. The company was incorporated as Mizra Medical Ltd in 2002. The company has grown to be the<br />

leading producer of latex disposable products in <strong>Israel</strong>. Mizra's first factory was opened in Holon, <strong>Israel</strong>, a<br />

southern suburb of Tel Aviv. The company has expanded and our main manufacturing plant is now located<br />

close to the Port of Ashdod. We carry a complete line of continence care products and distribute specialized<br />

products that provide solutions to the challenges faced by the elderly, handicapped, or anyone with special<br />

needs.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Disposable<br />

General Health, Urology, Infection Control<br />

Revenue Growth<br />

Technology & Product(s)<br />

Mizra Medical carries an extensive line of continence care products, and distributes specialized products<br />

that provide solutions to the challenges faced by the elderly, handicapped, or anyone with special needs.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Distribution, Alliances<br />

Distributors, Hospitals, Pharmacies<br />

Eastern Europe, USA, Canada, <strong>South</strong> America<br />

36


NanoVibronix<br />

Back to TOC<br />

Company at a Glance<br />

www.nanovibronix.com<br />

NanoVibronix develops innovative medical devices based on its proprietary therapeutic acoustic<br />

technology.<br />

The company's two main product lines are for catheter-related complications and for treatment of wounds,<br />

soft tissue and pain in a range of clinical applications.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Therapeutic Device (Personal Ultrasound)<br />

Infection Control, Urology, Wound Management<br />

Initial Revenues<br />

Technology & Product(s)<br />

UroShield - prevents biofilm formation on catheters, thereby decreasing risk for urinary tract infection,<br />

increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.<br />

PainShield - accelerate healing of chronic wounds, bone fractures, non-union of fractures and relief of<br />

pain.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Expand distributor network<br />

Distributors<br />

Germany, France, Italy, UK, Spain, and Scandinavia<br />

37


OHK Medical Devices Ltd.<br />

Back to TOC<br />

www.hemaclear.com<br />

Company at a Glance<br />

The creators of HemaClear® saw the need for a new, different kind of tourniquet, one that would be simple,<br />

safe, sterile, and more cost-effective than any device on the market today. They had a vision, and realized it.<br />

HemaClear® is the first and only single-use device that exsanguinates, occludes, and provides a clearer<br />

surgical field. Beginning with a sterile field allows surgeons to place the device closer to the site than ever<br />

before. Its narrower size provides a larger, dryer, and clearer surgical field, for a better view of anatomical<br />

structures. Instant, on-the-spot sterility, and greater access to the surgical site assures a safer, more<br />

successful surgical outcome.<br />

Its innovative technology not only reduces blood loss, infection, and the volume of ischemic tissue, it’s<br />

simplicity saves precious OR set-up time…as much as fifteen minutes…and over 100 separate steps that<br />

can add as much as $300 to every procedure.<br />

In fact, HemaClear® is so revolutionary, it represents the single greatest advance in tourniquet technology<br />

since the Esmarch bandage.<br />

HemaClear® has been proven worldwide in over 150,000 surgical cases… from the OR…to disaster-struck<br />

areas all around the world (including the recent earthquake in Haiti).<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment, General Surgery<br />

Orthopedic<br />

Revenue Growth<br />

Technology & Product(s)<br />

HemaClear is designed to create a bloodless field for limb surgery, quickly and effectively without wasting<br />

precious time and materials. In the center of the device, a specially engineered silicone ring exerts just<br />

enough circumferential pressure as it rolls up the limb to exsanguinate completely and occlude the blood<br />

vessels -- without damaging soft tissue and nerves.<br />

Factory calibrated and pre-set, HemaClear delivers uniform and reproducible results. Full range of sizes to<br />

accommodate almost every patient type, from pediatric to obese (limb circumference of 14 to 90 cm).<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Develop a distribution network<br />

Orthopedic surgeons<br />

Germany, Belgium, the Netherlands, Switzerland, Scandinavia<br />

38


Orpheus<br />

Back to TOC<br />

www.orpheus.co.il<br />

Company at a Glance<br />

Orpheus is a spin-off of 4UTV, a company which was established on 1999 and was a pioneer in the area of<br />

digital broadcasting and video on demand, (VOD), systems.<br />

Orpheus is considered to be at the leading edge of its core technology, and it has deployed a large number of<br />

VOD systems worldwide.<br />

The company, headquarted in <strong>Israel</strong>, hires top of the line system engineers.<br />

By using our experience in the area of VOD we have developed a unique telemedicine system, MedicVOD,<br />

which enables a medical team to archive, view and re-use video assets that were recorded during a live<br />

medical procedure such as surgery, endoscopy, ultrasound, etc.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices, Healthcare IT<br />

Endoscope and Accessories, Telemedicine, Research Equipment, Training, Internetbased<br />

Health Information, PACS Archiving<br />

Gastrointestinal, General Surgery, Gynecology<br />

Clinical Trials, Regulatory Approval<br />

Technology & Product(s)<br />

The proposed system, MedicVOD, is a VOD (Video On Demand) system that enables a medical team to<br />

archive, view and re-use video assets that were recorded during a live medical procedure such as surgery,<br />

endoscopy, ultra sound, etc.<br />

The video/audio taken is captured directly from the scope camera monitor of the device being used.<br />

The system is based on a VOD core system, with selected add-on components completing a full system<br />

adapted to medical needs. Major features of MedicVOD include:<br />

1. Digital recording of the medical procedure directly to an on-site server<br />

2. Efficient archiving of video assets to save storage resources<br />

3. Live broadcasting of a medical procedure to an unlimited number of viewers<br />

4. Smart and efficient data fetching while using dynamic categories to produce various statistics and reports<br />

5. Ability to watch videos at any location and at any time<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Strategic Alliances<br />

1. Distributers specializing in the endoscopy field; 2. Manufacturers of endoscopes<br />

and accessories.<br />

Worldwide<br />

39


Pegasus Medical Concepts<br />

Back to TOC<br />

www.pegasusmedical.net<br />

Company at a Glance<br />

Pegasus Medical is a US-<strong>Israel</strong>i company dedicated to providing modular storage hardware solutions along with stock<br />

management and software tools used to manage and control the usage of medical supplies in the point of care<br />

surrounding.<br />

We manufacture a broad line of dedicated ISO ABS modules for storage.<br />

Our ISO modules are integrated in different "packages" – cabinets, open racks, trolleys, electronic cabinets etc.<br />

The Pegasus philosophy is to increase storage capacity per square meter by using "smart" storage hardware, with<br />

dedicated software tools. We help our clients arrange and plan the entire hospital disposable item supply chain from<br />

the warehouse to the department level.<br />

Unlike other players in the market, we combine basic entry-level solutions like storage racks, treatment trolleys and<br />

storage trolleys side by side with high-end solutions like secured electronic cabinets.<br />

We offer electronic and RFID cabinets, used to control expensive disposables items. These systems utilize dedicated<br />

software, providing the user with different logistic methodologies, including Scan to Take, RFID Recognition and<br />

Kanban Inventory.<br />

We are constantly looking for new partners to help us expand into new markets.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment<br />

General Health, General Surgery<br />

Revenue Growth<br />

Technology & Product(s)<br />

ISO Module – a broad line of 60X40 ISO trays, dividers and side panel systems.<br />

Storage Carts – multiple heights and width range of mobile storage carts for the ISO modules, including Tambour door<br />

and glass doors solutions. High quality – durable aluminum and HPL structure.<br />

Treatment and Resuscitation Carts – general procedure carts as well as resuscitation carts equipped with retractable<br />

slides, bumpers, abs top and a broad line of accessories.<br />

Open rack system – open rack system for ISO module with telescopic or fixed slide. Provided in a knocked down<br />

modular structure. Can be implemented by the end user!<br />

Cabinets – aluminum/melamine/SS cabinets for general department OR rooms and interventional cardiology units.<br />

Point of Use Stock Management Tools – Pegasus Kan ban point of use stock management tools enables hospital to<br />

maintain accurate stock level system without overloading the medical staff's work.<br />

SmartCab – Modular cabinets with scan to take technology or RFID technology for the management of high value items<br />

in ORs, Cath labs and Angio labs.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Expanding our network of distributors in Europe and <strong>South</strong> America<br />

Recruiting new distributors<br />

Europe in General, France, the Netherlands, Scandinavia, Italy, Hungary, Bulgaria,<br />

Poland and <strong>South</strong> America<br />

40


Polytex Technologies Ltd.<br />

Back to TOC<br />

www.polytex.co.il<br />

Company at a Glance<br />

Polytex Technologies Ltd. provides advanced solutions for textile management such as distribution of<br />

uniforms, garments, special wear for clean rooms, operating rooms scrubs, hotel towels, etc. The Polytex<br />

solution is based on unique, patented developments, which provides the Polytex systems' great advantages<br />

in terms of speed and reliability of service, capacity and costs. Our systems are installed at various sites from<br />

factories as Intel R&D center to medical centers, including Hadassah Medical Center in Jerusalem and Val<br />

d'Hebron in Barcelona.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment<br />

General Health<br />

Revenue Growth<br />

Technology & Product(s)<br />

Polytex products are divided into textile dispensing units and textile return units for various applications. All<br />

of our products are based on patented technology developed by Polytex. The Polytex technology allows our<br />

systems to distribute folded items. Compared to other existing solutions, our systems provides the best<br />

solution in terms of speed and reliability in distributing the textile items, speed in loading the items to the<br />

system, very low maintenance needs, high capacity and relatively low costs.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

To find potential clients and distributors<br />

Hospitals, industrial laundries, dealers and distributors of industrial machinery for<br />

laundries, dealers and distributors of hospital logistics systems<br />

Worldwide<br />

41


Q Core Medical Ltd.<br />

Back to TOC<br />

www.Qcore.com<br />

Company at a Glance<br />

Q Core Medical is a leading developer and producer of medical infusion and feeding pumps for hospital,<br />

home ambulatory and veterinary use. We are a dynamic and growing company that has been developing<br />

and producing advanced new technologies and products at the rate of one every 18 months.<br />

The infusion pumps market has become a distinct market segment of ~ $3B in 2008, to grow to over<br />

$4.5B by 2015. Smart pumps such as the Q Core’s AP34 are becoming the device of choice for hospital<br />

and ambulatory care due to the enhanced safety, convenience and efficiency they provide. Our<br />

conveniently readable screens, easy programming and fail-safe operation make the healthcare<br />

professional's job that much easier. For the patient, Q Core's ambulatory pumps make homecare possible<br />

at a previously unachievable level of quality of life, while our veterinary pumps are reliably accurate no<br />

matter how rugged the conditions.<br />

Q Core Medical is privately owned company acquired in 2009 by Dr. Boaz Eitan. Prior to the acquisition of<br />

Q Core, Dr. Eitan became the owner of over 80 patents and founded Saifun Semiconductors Ltd., which<br />

later merged with Spansion Semiconductors. Dr. Eitan serves as CEO and Chairman of the Board of Q Core<br />

Medical.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Drug Delivery<br />

General Health, Oncology, Pediatrics, Prenatal, Veterinary<br />

Initial Revenues<br />

Technology & Product(s)<br />

Q Core Medical has developed multi-treatment, epidural, pain management and veterinary pumps.<br />

Alongside these pumps Q Core offers a wide selection of accessories including ergonomic bolus handles,<br />

cradles, and all types of disposable sets necessary for use with our platform.<br />

Our unique patents and development skill together with production and business understanding allow Q<br />

Core Medical to offer its innovative products at best cost structure in class, as well as a superior, fast<br />

paced product roadmap.<br />

All of Q Core’s pumps include Magnetic Flow Control technology (mcf), which dramatically reduces the<br />

power consumption level, flow accuracy and enhances the continuous nature of the flow, thereby<br />

increasing patient safety.<br />

The Magic Straw is Q Core's unique design. The Magic Straw is a disposable module attached to the<br />

pump as part of the administration set. It has a built-in dual safety feature, providing automatic anti-free<br />

flow protection and upstream/downstream occlusion protection. The Magic Straw is easy to install, and<br />

its unique design prevents incorrect installation of the tubing.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Initiate business dicussions for distribution of Q Core products in various<br />

territories in Europe<br />

Distributors for infusion pumps and medical devices<br />

France, UK, Spain, and the rest of Europe<br />

42


Shekel Scales Ltd.<br />

Back to TOC<br />

Company at a Glance<br />

www.shekelonline.com<br />

Shekel is a leading manufacturer and developer of scales and weighing solutions, providing thousands of<br />

customers worldwide with innovative retail, health care and OEM smart weighing solutions.<br />

With over 35 years of experience, Shekel partners with leading companies in the industry, including GE<br />

Health Care, IBM, Fujitsu, Data Logic, and many others.<br />

Since its inception, Shekel has grown steadily to establish its position as a significant innovation leader in<br />

the market. Shekel's outstanding combination of sophisticated software and core weighing engineering<br />

technology enables the company to offer creative solutions for a wide range of OEM weighing needs.<br />

Shekel implements strict quality control management to ensure the highest standards of its products.<br />

Shekel's Healthweigh TM line has positioned itself as one of the leading players in the healthcare scales<br />

industry. Healthweigh products excel in very high precision results, and are designed to be userfriendly.<br />

Shekel's systems were the world’s first to be integrated into warmers and incubators used to<br />

sustain premature babies.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices, Healthcare IT<br />

Medical Equipment, Diagnostic, Monitoring, Telemedicine, Internet-based Health<br />

Information, Decision Support System, Services<br />

General Health, Cardiovascular, Diabetics, Intensive Care, Primary Care, Obesity,<br />

Pediatrics, Veterinary<br />

Revenue Growth<br />

Technology & Product(s)<br />

• Shekel's products are designed for professional use, and they comply with the highest international<br />

standards, including OIML Class III and NTEP.<br />

• Shekel's physician scales are suitable for medical centers, clinics, hospitals and fitness centers. All<br />

Shekel scales are manufactured with advanced electronic technology, using environmentally friendly<br />

materials.<br />

• Shekel's professional neonatal scales are ergonomically designed for the newborn baby, and they<br />

include unique movement compensation technology that ensures highest accuracy, even when the<br />

baby moves during the weighing process.<br />

• Healthweigh TM , a wide range of scales for special needs, is the most professional solution for the<br />

needs of diverse medical sectors. Equipped with easy-to-access ramps, a simple and easy to activate<br />

key pad, pressure reducing cushioned seats and more, this range is oriented for extreme comfort,<br />

ease of operation and, most importantly, for protecting patient safety.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

1. Distributors of: medical devices for hospitals, clinics, physicians, long-term care<br />

equipment suppliers, and fitness centers (nationwide distributors, or very large<br />

regional distributors).<br />

2. Medical device manufacturers requiring embedded professional weighing<br />

systems.<br />

United States; United Kingdom; Europe (Germany: for OEM embedded solutions);<br />

Japan; Korea; China; India; Australia; New Zealand; Brazil<br />

43


Sialo Technology <strong>Israel</strong><br />

Back to TOC<br />

Company at a Glance<br />

www.sialotechnology.com<br />

Sialo Technology Ltd. provides medical solutions for the treatment of salivary gland diseases and other oral<br />

conditions. Sialo's flagship technology, salivary gland endoscopy, provides an accurate means of diagnosing<br />

and locating oral obstructions, such as salivary gland stones, and permits minimally invasive oral surgical<br />

procedures.<br />

The company's most exciting development – root canal endoscopy – is expected to have a significant impact<br />

on the dental market<br />

Sialo was founded in October 2002 and has been a publicly traded company listed on the Tel Aviv Stock<br />

Exchange (SALO) since February 2007<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Diagnostics, Endoscope and Accessories<br />

Dental, Ear Nose and Throat (ENT), Oral Care<br />

Initial Revenues<br />

Technology & Product(s)<br />

Sialo's endoscope solutions are marketed globally and allow doctors to perform minimally invasive<br />

procedures in their clinics in cases that previously required full surgery and gland removal. The company<br />

offers drains and balloons for use on salivary glands; Lithotripter, an extracorporeal shock wave therapy<br />

treatment for salivary gland disorders; and Salivascope, an endoscope system for the treatment of salivary<br />

glands.<br />

Sialo Technology offers a full product line of FDA approved disposable items – drains, balloons and baskets<br />

— used with advanced endoscopic techniques. Sialo also markets high quality, compact lithotriptors, both<br />

with and without an ultrasound unit, for breaking stones into small pieces.<br />

The company's most exciting development – root canal endoscopy – is expected to have a significant impact<br />

on the dental market. Sialo offers a tiny endoscope to enable improved visibility of the area under treatment,<br />

thereby markedly increasing the success rate of root canal procedures and preventing secondary<br />

complications. Potential applications include the detection of throat and mouth cancer.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Begin worldwide marketing by cooperation with distributors.<br />

Worldwide distributors.<br />

Worldwide<br />

44


Signal Business Development<br />

Back to TOC<br />

Company at a Glance<br />

www.signalbd.com<br />

Signal Business Development, a member of The Trendlines Group, leads the US business development efforts<br />

of non-US medtech companies to accelerate their penetration into the US market. Our extensive knowledge<br />

and experience as well as our contacts all along the value chain that brings medtech products to the US<br />

market, consistenly bring results in the form of deal-oriented success.<br />

A trusted company since 1993, our experienced in-house consulting team in the US and in our EMEA office<br />

in <strong>Israel</strong> leverages an extensive network of business and investment contacts to deliver: partner<br />

development (beta/clinical sites, distribution, OEM, licensing); sales channel development (strategic<br />

customers, trade show assistance, building rep networks); market studies; market strategy plans; business<br />

plans, investor presentations; English-language marketing communications (websites, brochures,<br />

newsletters, etc.).<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Services<br />

Business Development<br />

Revenue Growth<br />

Technology & Product(s)<br />

Our experienced consulting team researches markets to build industry maps, explore the competitive<br />

landscape, and show you the "bigger picture."<br />

We analyze your venture’s strengths and weaknesses to recommend sensible business models<br />

benchmarked to your industry and market.<br />

We plan your US market entry or expansion strategies and work together to formulate your business<br />

development roadmap.<br />

To implement your plans, we identify qualified opportunities, make introductions, organize your business<br />

trip, and follow up until the deal is closed.<br />

We develop fund-raising tools with you: a well thought out business plan that maximizes your venture’s<br />

value, a compelling investor presentation, and a door-opening "one-pager." We will coach you in your<br />

presentation delivery. And we will introduce you to our growing network of investors.<br />

We develop corporate identity briefs and write on-target marketing communications materials – all to drive<br />

your great venture forward.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Sell our proven abilities to bring non-US medtech companies into the US market<br />

Medtech companies already selling product into non-US markets that see the US<br />

market as a strategic business opportunity<br />

Western European countries<br />

45


Sion Biotext Medical<br />

Back to TOC<br />

Company at a Glance<br />

www.sb-medical.com<br />

Sion Biotext Medical Ltd. is leading manufacturer of single-use skin cleansing and treatment, wound care<br />

and surgical solutions for the professional health care sector.<br />

The rich product formulations provide additional values, in the cost per unit as well as the volumes needed<br />

for each usage. Sion Biotext Medical provides the products in a variety of package sizes and dispensing<br />

options, each one designed to address specific uses and needs.<br />

Our products are nurse orientated although technology is driving physician interest. We seek to reduce the<br />

cost of healing to the healthcare provider.<br />

The company’s Quality System is accredited to ISO 9001, ISO 13485 and GMP regulations. The products bear<br />

the CE mark certification.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Disposable, Implantable<br />

Cardiovascular, Infection Control, Ophthalmology, Orthopedic, Wound Management<br />

Revenue Growth<br />

Technology & Product(s)<br />

Cleansing & Care Line offers a wide range of skin antisepsis products used to minimize infections caused by skin<br />

pathogens, and includes:<br />

Chlorhexidine (0.5%) & Alcohol Prep Pads<br />

Chlorhexidine (2%) & Alcohol Prep Pads<br />

Alcohol Prep Pads and Swabsticks<br />

Lemon Glycerin Swabsticks<br />

Electrode Skin Prep Pads<br />

Adhesive Tape Remover Pads<br />

SkinCoat Prep Pads<br />

Skin Care and Patient Treatment products are delivered in pharmaceutical-grade bases and serve to protect the<br />

skin and maintain optimal skin integrity, and includes:<br />

Sterile Lubricant Jelly<br />

First Aid Ointments and Creams<br />

Zinc Oxide, Vitamin A&D Ointment<br />

Vitamin A&D Ointment<br />

Petrolatum Ointment<br />

Cooling Gel<br />

Wound Care Line combining the traditional bandage and the impregnated technology resulted a new age product<br />

line: Zinc/Calamine Paste Bandages for the management of venous leg ulcers and ICE COOL Elastic Bandage, a<br />

revolutionary product designed to deliver cold and compression to the afected area for treatment of sport<br />

injuries, bruises, inflamations and sprains.<br />

Surgical Line offers complete solution in the operating theater by providing products such as drapes, packs and<br />

staff clothing, customised procedure packs/trays.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Distribution, Alliances<br />

Clinics, Hospitals, Home Care<br />

Europe, US, Canada, <strong>South</strong> America, Australia<br />

46


SPO Medical Systems Ltd.<br />

Back to TOC<br />

www.spovitalsigns.com<br />

Company at a Glance<br />

SPO Medical Systems Is a medical company that develops and manufactures monitoring devices that capture<br />

vital signs using patented reflective technology.<br />

SPO Medical Systems has developed a unique Reflectance Pulse Oximetry (RPO) technology for noninvasively<br />

monitoring blood oxygen saturation and heart rate. The sensors are affixed to a single side of a<br />

body part, use low-power batteries, and incorporate wireless functionality. Partners are sought to distribute<br />

and provide technical support for current product lines within four key markets: Medical care; Home and<br />

remote-care; Sports and wellness; and Safety and security.<br />

Our non-invasive reflective technology provides cutting edge, rapid and reliable mobile response, using this<br />

features we developed a new sophisticated product to preventing suicides among prisoners and mentally<br />

ills.<br />

The product is used by the <strong>Israel</strong> Prison Service.<br />

Category, Sub-category & Therapeutic Area(s)<br />

Category:<br />

Sub Category:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Monitoring<br />

General Health<br />

Revenue Growth<br />

Technology & Product(s)<br />

There are two methods to measure pulse oximetry: by transmission through a body part or by reflection. In<br />

general, the transmission method can only be used on limited areas of the body, such as fingers, earlobes,<br />

etc. Furthermore, in some instances when the transmission method is used, physiological conditions such as<br />

stress and temperature can affect the accuracy of pulse oximetry readings.<br />

SPO Medical Systems has developed patented sensors that work accurately during physical activity. This<br />

technique uses a reflective method whereby a very small sensor placed on the body at various locations has<br />

the ability to measure oxygen saturation and heart pulse rate.<br />

Innovative aspects and main advantages:<br />

• The sensor technology very precisely captures vital cardiovascular parameters such as pulse rate, pulse<br />

rhythm and pulse pressure.<br />

• It consumes very little power, so it is useful for continuous monitoring of people in non-clinical<br />

environments.<br />

• It does not require tight skin contact. Therefore, it does not cause occlusion or discomfort and can be<br />

worn comfortably around the clock for long periods of time. It is small and lightweight enough to be<br />

easily embedded in wristwatch-type devices.<br />

Goal<br />

Objectives:<br />

Target businesses:<br />

Target Countries:<br />

Looking for distributors and cooperation to embeded our technology in other<br />

potential products.<br />

USA, Europe, All Countries<br />

47


Talshir Medical Technologies<br />

Back to TOC<br />

www.talshir.co.il<br />

Company at a Glance<br />

Talshir Medical Technologies Ltd., founded in 2008, is an exclusive licensed manufacturer and marketer of<br />

NeuroVision – a technology that enhances vision neurologically and is used to improve and correct<br />

various visual impairments.<br />

NeuroVision was developed in <strong>Israel</strong>, where the company was established in 1999 by Dr. Uri Polat, a brain<br />

scientist from the Weizmann Institute of Science. In August 2001, NeuroVision received FDA 510(K)<br />

approval for the treatment of Adult Amblyopia (lazy eye), which until then has been considered untreatable.<br />

The company relocated to Singapore in 2004 under the company name NeuroVision, Inc. due to government<br />

interest in the treatment of pediatric myopia in the Asia-Pacific Region. During this time, the technology has<br />

successfully treated more than 3,000 patients in Europe, the US, and Asia. In 2009, NeuroVision was<br />

purchased by RevitalVision LLC, and operations were relocated to the United States in Kansas City, Kansas.<br />

The company's studies have been published in multiple peer reviewed scientific publications. Awareness and<br />

recognition of the company and the technology is consistently increasing in the US and worldwide.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment<br />

Ophthalmology<br />

Revenue Growth<br />

Technology & Product(s)<br />

The NeuroVision technology is a non-invasive, patient-specific, perceptual learning program based on<br />

visual stimulation. It facilitates neural connections at the cortical level through a computerized visual<br />

training regime using Gabor patches, to improve contrast sensitivity and visual acuity. As visual perception<br />

depends on both the optical input received from the eye and the neural processing of that input in the visual<br />

cortex, NeuroVision technology improves quality of vision (contrast sensitivity and visual acuity) by<br />

enhancing neural processing in the primary visual cortex.<br />

The NeuroVision training system is interactive web-based computer software that provides a series of<br />

individualized visual stimuli, which are designed to enhance the neural interactions in the visual cortex. The<br />

treatment is sold only through eye doctors, who examine and monitor the patient's progress.<br />

The average vision improvement is more than 2 lines on the visual acuity eye chart and 100% increase in<br />

contrast sensitivity.<br />

Neurovision is the only clinically proven and FDA approved therapy for Amblyopic Adults. The program is also<br />

used to treat Low Myopia, Early Presbyopia, Post Cataract, Post LASIK (laser) and Low Vision patients. FDA &<br />

CE-Mark approved.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Find distributors in Europe, Asia and the Middle East.<br />

Distributors<br />

Europe, Asia and the Middle East<br />

48


TavTech Ltd.<br />

TavTech<br />

www.tav-tech.com<br />

Back to TOC<br />

Company at a Glance<br />

TavTech Ltd. is an innovator of state-of-the-art technology, incorporating jet aviation principles and<br />

engineering. TavTech's unique systems use only natural components - air (or medical gas) and water -<br />

accelerated to supersonic speeds to achieve the desire effect on tissue. The technology is patented and has<br />

broad application across the medical spectrum.<br />

Aesthetic Medicine and Cosmetology – TavTech's industry-leading exclusive technology brings new<br />

dimensions to Aesthetic Medicine. TavTech's JetPeel TM systems provide multi-functional skin rejuvenation<br />

using nature's own elements – air, oxygen (or other medical gas) and saline solution. They are designed for<br />

skin rejuvenation, facial resurfacing, removal of age and hyperpigmentation spots, peri-oral wrinkles, facial<br />

deep cleansing (pores, comedones) and moisturizing, and for use on scars, acne, stretch marks, scalp and a<br />

variety of other applications, all painlessly.<br />

TavTech has launched a new product – Jet-M – that is perfectly positioned to meet the needs of the changing<br />

market. Jet-M will provide non-traditional physicians, medspas, and para-medical practitioners with<br />

affordable, multi-function treatment procedures for the aesthetic market (Please visit our website www.tavtech.com)<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Medical Equipment<br />

Dermatology and Aesthetics<br />

Revenue Growth<br />

Technology & Product(s)<br />

Jet aviation engineering is being used by TavTech to meet the needs of the rapidly expanding aesthetic, skin<br />

care and wound management markets. TavTech's patented technology creates a supersonic, two-phase jet<br />

of micro-droplets consisting of saline solution and gas (air or medical gas) that is accelerated to velocities<br />

that reach 200m/sec., providing a versatile and precise means for performing a wide variety of skin<br />

treatments.<br />

The pressure created by the high-velocity jet stretches the skin at the point of contact, causing<br />

"barophoresis" due to pressure variance; the skin in the high-pressure zone forms a concave surface and<br />

micro-canals in the outer layer of the skin broaden as the skin stretches and new canals are created. This<br />

process facilitates hydration, cleansing and purifying of the treated area, opens access to the skin's inner<br />

layers, allowing for deeper penetration, and the introduction of vitamins, anti-aging and other solutions.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Identify Partners/Distributors<br />

Qualified Partners/Distributors<br />

Germany, Australia, France<br />

49


VitalCare Medical<br />

Back to TOC<br />

www.vitalcaremedical.com<br />

Company at a Glance<br />

VitalCare Medical is pioneering the development of advanced, non-invasive software diagnostic<br />

technologies that address complex, extensive cardiac data acquisition and analysis challenges with broad<br />

potential applications.<br />

Established in 2008 by a team of world-renowned scientists, the company's headquarters are based in<br />

<strong>Israel</strong>. The company's flagship HC-100 system received CE-Mark and ISO 13485:2003 certification, and is<br />

currently being tested in large-scale retrospective studies in Europe and the US, and a prospective study in<br />

<strong>Israel</strong>.<br />

Category, Subcategory & Therapeutic Area(s)<br />

Category:<br />

Subcategory:<br />

Therapeutic Area(s):<br />

Company Status:<br />

Medical Devices<br />

Diagnostic<br />

Cardiovascular<br />

Initial Revenues<br />

Technology & Product(s)<br />

The company's flagship HeartCheck-100 (HC-100) is a patent-pending diagnostic technology that<br />

calculates and generates an HRV parameter that offers potentially powerful predictive and prognostic value.<br />

It is currently being tested for use by physicians as a cost-effective gateway test for patients at risk for<br />

ventricular tachycardia, congestive heart failure, and cardiac arrhythmia.<br />

Goal<br />

Objectives:<br />

Target Businesses:<br />

Target Countries:<br />

Strategic Alliances<br />

Worldwide<br />

50


<strong>Israel</strong><br />

inspired by innovation<br />

This publication is for informational purposes only. While every effort has been made to ensure that the information is correct, The <strong>Israel</strong><br />

Export & International Cooperation Institute assumes no responsibility for damages, financial or otherwise, caused by the information herein.<br />

© September 2010 The <strong>Israel</strong> Export & International Cooperation Institute | Production: IEICI Media & Production Division | Editing: Joseph Alexander<br />

Design: Graphic Touch

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!